EUVIMEDEUVIMED entdecken
Crossref

Bacillus subtilis ZB423: 90‐Day repeat dose oral (gavage) toxicity study in Wistar rats

Vijayakumar K N, Swati S Bamne, Johnson Crasta, Satish Kumar C, Ramakrishna M Bhat, Bentley M Shuster, John W K Oliver iD, Zachary D Abbott

Journal of Applied Toxicology · 2024-12 · 44 (12) · 1874-1885

DOI: 10.1002/jat.4677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 21.08.2024. Verfasst von Vijayakumar K N und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adgyl Lifesciences Private Limited (Formerly Department of Safety Assessment, Eurofins Advinus Limited), Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Rats, Wistar, Bacillus subtilis, Probiotics, No-Observed-Adverse-Effect Level. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel genetically modified probiotic Bacillus subtilis ZB423 was assessed in a 90‐day repeated‐dose oral toxicity study adhering to Good Laboratory Practice (GLP) and Organization for Economic Cooperation and Development (OECD) guidelines. Spray‐dried spores at a concentration of 1.1E12 CFU/g were administered at doses of 130, 260, and 519 mg/kg body weight/day correlating to 1.43 × 10 11 , 2.86 × 10 11 , and 5.71 × 10 11 CFU/kg/day, respectively, by oral gavage to Wistar rats for a period of 90 consecutive days. Results showed no toxicologically relevant findings for B. subtilis ZB423 from measured parameters. The no observed adverse effect level (NOAEL) of B. subtilis ZB423 is 519 mg/kg body weight/day corresponding to 5.71 × 10 11 CFU/kg/day for lyophilized B. subtilis ZB423 spores under the test conditions employed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, WistarBacillus subtilisProbioticsNo-Observed-Adverse-Effect LevelAnimalsMaleAdministration, OralFemaleRatsSpores, BacterialBody WeightOrgan SizeDose-Response Relationship, Drug

Stichwörter der Autor:innen

B. subtilis ZB423 sporesWistar ratsfood ingredientsafetysub‐chronic toxicity

Autor:innen und Institutionen

  • Adgyl Lifesciences Private Limited (Formerly Department of Safety Assessment, Eurofins Advinus Limited), Bengaluru, Karnataka, India.
  • ZBiotics Company, San Francisco, California, USA.

ORCID-Profile: John W K Oliver

Zitieren

APA

K N, V., Bamne, S. S., Crasta, J., Kumar C, S., Bhat, R. M., Shuster, B. M., Oliver, J. W. K., & Abbott, Z. D. (2024). Bacillus subtilis ZB423: 90‐Day repeat dose oral (gavage) toxicity study in Wistar rats. Journal of Applied Toxicology, 44(12), 1874-1885. https://doi.org/10.1002/jat.4677

Vancouver

K N V, Bamne SS, Crasta J, Kumar C S, Bhat RM, Shuster BM, et al. Bacillus subtilis ZB423: 90‐Day repeat dose oral (gavage) toxicity study in Wistar rats. Journal of Applied Toxicology. 2024;44(12):1874-1885. doi:10.1002/jat.4677

BibTeX
@article{KN2024,
  author = {K N, Vijayakumar and Bamne, Swati S and Crasta, Johnson and Kumar C, Satish and Bhat, Ramakrishna M and Shuster, Bentley M and Oliver, John W K and Abbott, Zachary D},
  title = {Bacillus subtilis ZB423: 90‐Day repeat dose oral (gavage) toxicity study in Wistar rats},
  journal = {Journal of Applied Toxicology},
  year = {2024},
  volume = {44},
  number = {12},
  pages = {1874--1885},
  doi = {10.1002/jat.4677}
}
Kostenlos starten →